45 results
Page 2 of 3
8-K/A
EX-99.3
9lq97 6ui35qsrt9
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.1
vo9o6k5vf25m3xo5p
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.2
8979f68
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K
EX-99.3
w7hgpfc
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
DEFM14A
tbwjvky b41b7b4msq
2 Feb 21
Proxy related to merger
6:10am
424B3
16bmbfa3
2 Feb 21
Prospectus supplement
6:05am
S-4/A
tr6n83dpj a0c5419
29 Jan 21
Registration of securities issued in business combination transactions (amended)
5:01pm
S-4/A
EX-99.1
o9293ldq2 tpb6ms8xw
29 Jan 21
Registration of securities issued in business combination transactions (amended)
5:01pm
S-4
4313r rcb1
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
8-K
EX-99.1
hxamf
26 Oct 20
NantKwest Names Richard Adcock Chief Executive Officer
5:05pm